Identification of Candida dubliniensis in a prospective study of patients in the United States

Journal of Clinical Microbiology

Volumn 37, Issue 2, 1999, Pages 321-326

  Jabra Rizk, Mary Ann ^a   Baqui, A A M A ^a   Kelley, Jacqueline I ^a   Falkler Jr , William A ^a   Merz, William G ^b   Meiller, Timothy F ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA DUBLINIENSIS; CANDIDIASIS; ELECTROPHORESIS; FEMALE; FUNGUS IDENTIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UNITED STATES;

EID: 0032902932     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.2.321-326.1999     Document Type: Article

References (27)

1. Boerlin, P., F. Loerlin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33:1129-1135.
2. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanky. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
3. Elie, C. M., B. A. Lasker, L. W. Mayer, W. R. Pruitt, G. Smith, D. Rimland, L. Gallagher, E. Reiss, C. J. Morrison, and M. M. McNeil. 1998. Rapid differentiation of Candida dubliniensis from atypical C. albicans isolates using species-specific DNA probes, abstr. C-290. p. 179. In Abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology, Washington, D.C.
4. Isenberg, H. D. (ed.) 1992. In vitro antifungal susceptibility testing of yeasts, vol. I. American Society for Microbiology, Washington, D.C.
5. Kaufmann, C. S., and W. G. Merz. 1989. Electrophoretic karyotypes of Torulopsis glabrata. J. Clin. Microbiol. 27:2165-2168.
6. King, D., J. Rhine-Chalberg, M. A. Pfaller, S. A. Moser, and W. G. Merz. 1995. Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J. Clin. Microbiol. 33:1467-1470.
7. Kirkpatrick, W. R., S. G. Revankar, R. K. McAtee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
8. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700.
9. Merz, W. G. 1990. Candida albicans strain delineation. Clin. Microbiol. Rev. 3:321-334.
10. Merz, W. G., U. Khazan, M. A. Jabra-Rizk, L.-C. Wu, G. J. Osterhout, and P. F. Lehmann. 1992. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J. Clin. Microbiol. 30:449-454.
11. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HlV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41: 617-623.
12. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
14. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873.
15. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
16. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Barlett, A. Espinel-Ingroff, M. A. Ghannoum, et al. 1997. Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
17. Salkin, I. F., W. R. Pruitt, A. A. Padhye, D. Sullivan, D. Coleman, and D. H. Pincus. 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J. Clin. Microbiol. 36:1467.
18. Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Goosens. 1997. Use of specialized isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Infect. Dis. 16:296-300.
19. Sullivan, D., D. Bennett, M. Henman, P. Harwood, S. Flint, F. Mulcahy, D. Shanley, and D. Coleman. 1993. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J. Clin. Microbiol. 31:2124-2133.
20. Sullivan, D., T. Westermemg, K. A. Haynes, D. Bennett, and D. Coleman. 1995. Candida dubliniensis sp. nov. = phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 141:1507-1521.
21. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
22. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
23. Sullivan, D. J. 1998. Presentation: molecular epidemiological analysis of Candida dubliniensis, a newly described pathogen, symposium 163/F, p. 26. In Abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology, Washington, D.C.
24. Vazquez, J. A., L. M. Dembry, V. Sanchez, M. A. Vazquez. J. D. Sobel, C. Dmuchowski, and M. J. Zervos. 1998. Nosocomial Candida glabrata colonization: an epidemiologic study. J. Clin. Microbiol. 36:421-426.
25. Warren, N. G., and K. C. Hazen. 1995. Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737. In P. E. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. N. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
26. Wingard, J., W. Merz, and R. Saral. 1979. Candida tropicalis: a major pathogen in immunocompromised patients. Ann. Intern. Med. 91:529-543.
27. Wingard, J. R., W. G. Merz, G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 18:1274-1277.